Uk is very "chipper" about the(ir) Oxford (That's how they refer to it and you wouldn't blame them tbf) vaccine.Ruckedtobits wrote: ↑February 2nd, 2021, 10:58 pm Some good news from British researchers about the AZ vaccine:
a) The AstraZenaca vaccine retains high efficacy in protecting against the virus for at least three months after the initial jab; and
b) A benefit not originally claimed for the AZ vaccine is that, two weeks after the initial jab, the vaccinated individual has a dramatically reduced capacity to transmit the virus. Precisely how much less transmission is unclear as yet (more research time required) but thus far the estimated reduction is c. 60%.
The bad news for the AZ company is that French Medicine regulators, like their German counterparts, have not approved the vaccine from the Anglo-Swedish company, for over 65s.
No vaccine has yet been trialled and approved from either a French or a German pharmaceutical company.
They must have similar data on the Pfizer vaccine but perhaps don't want to go public on it because it's not their vaccine.
There is a definite feel good sentiment building in the UK now because their case numbers are really starting to fall which is of direct benefit to us too because of the border with 6 counties.
Either way it's great news for the world because the Oxford vaccine is effective, cheap and easy to distribute.